Castration-resistant prostate cancer (CRPC) is still a lethal disease even after the development of a new generation of hormonal drugs or chemotherapy, and thus the development of novel therapeutic ...

While capable of delivering 900 A continuously and 5,000 A for short periods, the new Ingvar primary current injection test set from Megger is readily portable, making it suitable for on-site use, ...